The GSK3 kinase and LZTR1 protein regulate the stability of Ras family proteins and the proliferation of pancreatic cancer cells

Ras family proteins are membrane-bound GTPases that control proliferation, survival, and motility. Many forms of cancers are driven by the acquisition of somatic mutations in a RAS gene. In pancreatic cancer (PC), more than 90% of tumors carry an activating mutation in KRAS. Mutations in components...

Full description

Bibliographic Details
Main Authors: Chitra Palanivel, Neha Chaudhary, Parthasarathy Seshacharyulu, Jesse L. Cox, Ying Yan, Surinder K. Batra, Michel M. Ouellette
Format: Article
Language:English
Published: Elsevier 2022-03-01
Series:Neoplasia: An International Journal for Oncology Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1476558622000021
_version_ 1818295928399855616
author Chitra Palanivel
Neha Chaudhary
Parthasarathy Seshacharyulu
Jesse L. Cox
Ying Yan
Surinder K. Batra
Michel M. Ouellette
author_facet Chitra Palanivel
Neha Chaudhary
Parthasarathy Seshacharyulu
Jesse L. Cox
Ying Yan
Surinder K. Batra
Michel M. Ouellette
author_sort Chitra Palanivel
collection DOAJ
description Ras family proteins are membrane-bound GTPases that control proliferation, survival, and motility. Many forms of cancers are driven by the acquisition of somatic mutations in a RAS gene. In pancreatic cancer (PC), more than 90% of tumors carry an activating mutation in KRAS. Mutations in components of the Ras signaling pathway can also be the cause of RASopathies, a group of developmental disorders. In a subset of RASopathies, the causal mutations are in the LZTR1 protein, a substrate adaptor for E3 ubiquitin ligases that promote the degradation of Ras proteins. Here, we show that the function of LZTR1 is regulated by the glycogen synthase kinase 3 (GSK3). In PC cells, inhibiting or silencing GSK3 led to a decline in the level of Ras proteins, including both wild type Ras proteins and the oncogenic Kras protein. This decline was accompanied by a 3-fold decrease in the half-life of Ras proteins and was blocked by the inhibition of the proteasome or the knockdown of LZTR1. Irrespective of the mutational status of KRAS, the decline in Ras proteins was observed and accompanied by a loss of cell proliferation. This loss of proliferation was blocked by the knockdown of LZTR1 and could be recapitulated by the silencing of either KRAS or GSK3. These results reveal a novel GSK3-regulated LZTR1-dependent mechanism that controls the stability of Ras proteins and proliferation of PC cells. The significance of this novel pathway to Ras signaling and its contribution to the therapeutic properties of GSK3 inhibitors are both discussed.
first_indexed 2024-12-13T03:55:26Z
format Article
id doaj.art-fecd7e5ec4184873b2e9116838a95734
institution Directory Open Access Journal
issn 1476-5586
language English
last_indexed 2024-12-13T03:55:26Z
publishDate 2022-03-01
publisher Elsevier
record_format Article
series Neoplasia: An International Journal for Oncology Research
spelling doaj.art-fecd7e5ec4184873b2e9116838a957342022-12-22T00:00:38ZengElsevierNeoplasia: An International Journal for Oncology Research1476-55862022-03-01252840The GSK3 kinase and LZTR1 protein regulate the stability of Ras family proteins and the proliferation of pancreatic cancer cellsChitra Palanivel0Neha Chaudhary1Parthasarathy Seshacharyulu2Jesse L. Cox3Ying Yan4Surinder K. Batra5Michel M. Ouellette6Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198, USA.Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198, USA.; Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE 68198, USA.Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE 68198, USA.Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE 68198, USA.Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE 68198, USA.; Department of Radiation Oncology, University of Nebraska Medical Center, Omaha, NE 68198, USA.Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE 68198, USA.Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198, USA.; Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE 68198, USA.; Corresponding author at: Department of Internal Medicine, Division of Gastroenterology and Hepatology, University of Nebraska Medical Center, 985870 Nebraska Medical Center, Omaha, NE 68198-5870, USA.Ras family proteins are membrane-bound GTPases that control proliferation, survival, and motility. Many forms of cancers are driven by the acquisition of somatic mutations in a RAS gene. In pancreatic cancer (PC), more than 90% of tumors carry an activating mutation in KRAS. Mutations in components of the Ras signaling pathway can also be the cause of RASopathies, a group of developmental disorders. In a subset of RASopathies, the causal mutations are in the LZTR1 protein, a substrate adaptor for E3 ubiquitin ligases that promote the degradation of Ras proteins. Here, we show that the function of LZTR1 is regulated by the glycogen synthase kinase 3 (GSK3). In PC cells, inhibiting or silencing GSK3 led to a decline in the level of Ras proteins, including both wild type Ras proteins and the oncogenic Kras protein. This decline was accompanied by a 3-fold decrease in the half-life of Ras proteins and was blocked by the inhibition of the proteasome or the knockdown of LZTR1. Irrespective of the mutational status of KRAS, the decline in Ras proteins was observed and accompanied by a loss of cell proliferation. This loss of proliferation was blocked by the knockdown of LZTR1 and could be recapitulated by the silencing of either KRAS or GSK3. These results reveal a novel GSK3-regulated LZTR1-dependent mechanism that controls the stability of Ras proteins and proliferation of PC cells. The significance of this novel pathway to Ras signaling and its contribution to the therapeutic properties of GSK3 inhibitors are both discussed.http://www.sciencedirect.com/science/article/pii/S1476558622000021Pancreatic cancerRASLZTR1GSK3Protein stability
spellingShingle Chitra Palanivel
Neha Chaudhary
Parthasarathy Seshacharyulu
Jesse L. Cox
Ying Yan
Surinder K. Batra
Michel M. Ouellette
The GSK3 kinase and LZTR1 protein regulate the stability of Ras family proteins and the proliferation of pancreatic cancer cells
Neoplasia: An International Journal for Oncology Research
Pancreatic cancer
RAS
LZTR1
GSK3
Protein stability
title The GSK3 kinase and LZTR1 protein regulate the stability of Ras family proteins and the proliferation of pancreatic cancer cells
title_full The GSK3 kinase and LZTR1 protein regulate the stability of Ras family proteins and the proliferation of pancreatic cancer cells
title_fullStr The GSK3 kinase and LZTR1 protein regulate the stability of Ras family proteins and the proliferation of pancreatic cancer cells
title_full_unstemmed The GSK3 kinase and LZTR1 protein regulate the stability of Ras family proteins and the proliferation of pancreatic cancer cells
title_short The GSK3 kinase and LZTR1 protein regulate the stability of Ras family proteins and the proliferation of pancreatic cancer cells
title_sort gsk3 kinase and lztr1 protein regulate the stability of ras family proteins and the proliferation of pancreatic cancer cells
topic Pancreatic cancer
RAS
LZTR1
GSK3
Protein stability
url http://www.sciencedirect.com/science/article/pii/S1476558622000021
work_keys_str_mv AT chitrapalanivel thegsk3kinaseandlztr1proteinregulatethestabilityofrasfamilyproteinsandtheproliferationofpancreaticcancercells
AT nehachaudhary thegsk3kinaseandlztr1proteinregulatethestabilityofrasfamilyproteinsandtheproliferationofpancreaticcancercells
AT parthasarathyseshacharyulu thegsk3kinaseandlztr1proteinregulatethestabilityofrasfamilyproteinsandtheproliferationofpancreaticcancercells
AT jesselcox thegsk3kinaseandlztr1proteinregulatethestabilityofrasfamilyproteinsandtheproliferationofpancreaticcancercells
AT yingyan thegsk3kinaseandlztr1proteinregulatethestabilityofrasfamilyproteinsandtheproliferationofpancreaticcancercells
AT surinderkbatra thegsk3kinaseandlztr1proteinregulatethestabilityofrasfamilyproteinsandtheproliferationofpancreaticcancercells
AT michelmouellette thegsk3kinaseandlztr1proteinregulatethestabilityofrasfamilyproteinsandtheproliferationofpancreaticcancercells
AT chitrapalanivel gsk3kinaseandlztr1proteinregulatethestabilityofrasfamilyproteinsandtheproliferationofpancreaticcancercells
AT nehachaudhary gsk3kinaseandlztr1proteinregulatethestabilityofrasfamilyproteinsandtheproliferationofpancreaticcancercells
AT parthasarathyseshacharyulu gsk3kinaseandlztr1proteinregulatethestabilityofrasfamilyproteinsandtheproliferationofpancreaticcancercells
AT jesselcox gsk3kinaseandlztr1proteinregulatethestabilityofrasfamilyproteinsandtheproliferationofpancreaticcancercells
AT yingyan gsk3kinaseandlztr1proteinregulatethestabilityofrasfamilyproteinsandtheproliferationofpancreaticcancercells
AT surinderkbatra gsk3kinaseandlztr1proteinregulatethestabilityofrasfamilyproteinsandtheproliferationofpancreaticcancercells
AT michelmouellette gsk3kinaseandlztr1proteinregulatethestabilityofrasfamilyproteinsandtheproliferationofpancreaticcancercells